166 related articles for article (PubMed ID: 24927973)
1. Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention.
Abe M; Morimoto T; Akao M; Furukawa Y; Nakagawa Y; Shizuta S; Ehara N; Taniguchi R; Doi T; Nishiyama K; Ozasa N; Saito N; Hoshino K; Mitsuoka H; Toma M; Tamura T; Haruna Y; Kita T; Kimura T
Am J Cardiol; 2014 Aug; 114(3):362-8. PubMed ID: 24927973
[TBL] [Abstract][Full Text] [Related]
2. Impact of Transient or Persistent Contrast-induced Nephropathy on Long-term Mortality After Elective Percutaneous Coronary Intervention.
Abe M; Morimoto T; Nakagawa Y; Furukawa Y; Ono K; Kato T; Kadota K; Ando K; Ishii M; Masunaga N; Akao M; Kimura T
Am J Cardiol; 2017 Dec; 120(12):2146-2153. PubMed ID: 29106836
[TBL] [Abstract][Full Text] [Related]
3. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
4. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
[TBL] [Abstract][Full Text] [Related]
6. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome.
Senoo T; Motohiro M; Kamihata H; Yamamoto S; Isono T; Manabe K; Sakuma T; Yoshida S; Sutani Y; Iwasaka T
Am J Cardiol; 2010 Mar; 105(5):624-8. PubMed ID: 20185007
[TBL] [Abstract][Full Text] [Related]
7. Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease.
Neyra JA; Shah S; Mooney R; Jacobsen G; Yee J; Novak JE
Nephrol Dial Transplant; 2013 Jun; 28(6):1463-71. PubMed ID: 23585585
[TBL] [Abstract][Full Text] [Related]
8. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implications of Contrast-Induced Nephropathy in Patients Without Baseline Renal Dysfunction Undergoing Coronary Angiography.
Chen SQ; Liu Y; Smyth B; Li HL; Sun GL; Chen ZJ; Zhou YL
Heart Lung Circ; 2019 Jun; 28(6):866-873. PubMed ID: 29960836
[TBL] [Abstract][Full Text] [Related]
10. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
[TBL] [Abstract][Full Text] [Related]
11. The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.
Appleby CE; Ivanov J; Lavi S; Mackie K; Horlick EM; Ing D; Overgaard CB; Seidelin PH; von Harsdorf R; Dzavík V
Circ Cardiovasc Interv; 2009 Aug; 2(4):309-16. PubMed ID: 20031733
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry.
Valle JA; McCoy LA; Maddox TM; Rumsfeld JS; Ho PM; Casserly IP; Nallamothu BK; Roe MT; Tsai TT; Messenger JC
Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404621
[TBL] [Abstract][Full Text] [Related]
13. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
[TBL] [Abstract][Full Text] [Related]
14. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
[TBL] [Abstract][Full Text] [Related]
15. Fragmented QRS complex predicts contrast-induced nephropathy and in-hospital mortality after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Kurtul A; Duran M
Clin Cardiol; 2017 Apr; 40(4):235-242. PubMed ID: 28244599
[TBL] [Abstract][Full Text] [Related]
16. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
[TBL] [Abstract][Full Text] [Related]
18. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.
Harjai KJ; Raizada A; Shenoy C; Sattur S; Orshaw P; Yaeger K; Boura J; Aboufares A; Sporn D; Stapleton D
Am J Cardiol; 2008 Mar; 101(6):812-9. PubMed ID: 18328846
[TBL] [Abstract][Full Text] [Related]
19. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
Pyxaras SA; Sinagra G; Mangiacapra F; Perkan A; Di Serafino L; Vitrella G; Rakar S; De Vroey F; Santangelo S; Salvi A; Toth G; Bartunek J; De Bruyne B; Wijns W; Barbato E
Am J Cardiol; 2013 Mar; 111(5):684-8. PubMed ID: 23261003
[TBL] [Abstract][Full Text] [Related]
20. Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial.
Crimi G; Leonardi S; Costa F; Ariotti S; Tebaldi M; Biscaglia S; Valgimigli M
Catheter Cardiovasc Interv; 2015 Jul; 86(1):E19-27. PubMed ID: 25703119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
